Altman Z-Score
-6.70
NaN%
Thu, 06 Feb 2025 21:00:00 GMT
Summary
- As of March 12, 2025, RVNC Altman Z-Score is -6.70, with the most recent change of null (null) on February 6, 2025.
- RVNC current Altman Z-Score indicates the stock has a high bankruptcy risk.
Performance
RVNC Altman Z-Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Altman Z-Score Formula
Z-Score = 1.2*A + 1.4*B + 3.3*C + 0.6*D + 1.0*E- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
- A = Working Capital / Total Assets
- B = Retained Earnings / Total Assets
- C = EBIT / Total Assets
- D = Market Cap / Total Liabilities
- E = Revenue / Total Assets
RVNC Altman Z-Score Trends
PeriodPeriod | Altman Z-ScoreAltman Z-Score | PricePrice | Market capMarket cap |
---|---|---|---|
1 m1 month | 0.0% | 0.0% | 0.0% |
3 m3 months | +0.9% | +18.1% | +18.1% |
6 m6 months | -4.4% | -44.3% | -43.9% |
ytdytd | +0.9% | +19.3% | +19.3% |
1 y1 year | -3.7% | -40.4% | -40.0% |
5 y5 years | -1318.2% | -76.7% | -57.1% |
Revance Therapeutics Altman Z-Score History
Date | Value |
---|---|
2024 | -6.76(+7.1%) |
2023 | -6.31(+71.5%) |
2022 | -3.68(+10.5%) |
2021 | -3.33(-612.3%) |
2020 | 0.65(+97.0%) |
Date | Value |
---|---|
2019 | 0.33(+57.1%) |
2018 | 0.21(-99.2%) |
2017 | 26.33(+170.3%) |
2016 | 9.74(-59.7%) |
2015 | 24.19(+82.6%) |
2014 | 13.25 |
FAQ
- What is Revance Therapeutics altman z-score?
- What is RVNC altman z-score year-to-date change?
- What is Revance Therapeutics altman z-score year-on-year change?
What is Revance Therapeutics altman z-score?
The current altman z-score of RVNC is -6.70
What is RVNC altman z-score year-to-date change?
Revance Therapeutics altman z-score has changed by +0.06 (+0.89%) since the beginning of the year
What is Revance Therapeutics altman z-score year-on-year change?
Over the past year, RVNC altman z-score has changed by -0.24 (-3.72%)